neximmune(neximmune盘前大涨超65%
NexImmune(NEXI):
NexImmune(NEXI) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-23-001467 Act: 34 Size: 54 KB 网页链接
NexImmune(NEXI):
NexImmune(NEXI) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-021889 Size: 7 KB 网页链接
NexImmune(NEXI):
智通财经APP获悉,临床阶段生物技术公司NexImmune(NEXI.US)表示,新的积极的临床前数据显示,其AIM ACT免疫疗法所生产的T细胞增强了对双特异性T细胞接合子(BiTE)疗法的反应。受此消息提振,截至发稿,NexImmune周四美股盘前大涨超65%,... 网页链接
NexImmune(NEXI):
NexImmune(NEXI) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-035848 Act: 34 Size: 57 KB 网页链接
NexImmune(NEXI):
NexImmune(NEXI) 8-K Current report, item 7.01 Accession Number: 0001193125-23-067727 Act: 34 Size: 143 KB 网页链接
NexImmune(NEXI):
NexImmune(NEXI) 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001538210-23-000007 Act: 34 Size: 11 MB 网页链接
NexImmune(NEXI):
NexImmune(NEXI) 8-K Current report, items 2.02 and 9.01 Accession Number: 0001538210-23-000006 Act: 34 Size: 261 KB 网页链接
NexImmune(NEXI):
NexImmune(NEXI) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-035847 Act: 34 Size: 41 KB 网页链接
NexImmune(NEXI):
NexImmune(NEXI) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-033096 Act: 34 Size: 138 KB 网页链接





